Corcept Therapeutics (CORT) P/E ratio

P/E ratio today
52.7×

Corcept Therapeutics (CORT) trades at 52.7× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 42.4×. That is 3.6% higher than the 41.0× of fiscal 2024. Figures as of 18 Nov 2026, 06:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
52.7×
P/E ratio, fiscal 2025
42.4×
Change on fiscal 2024
+3.6%
Highest on record
103.7×fiscal 2016
Lowest on record
15.7×fiscal 2019
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Corcept Therapeutics P/E ratio, in more detail

Today's figure is 24.1% above the fiscal 2025 year-end.

Across the 10 fiscal year-ends on record (2016–2025), the highest was 103.7× in fiscal 2016 and the lowest 15.7× in fiscal 2019. Today's P/E ratio is higher than at 90% of the 10 fiscal year-ends on record; their median is 27.1×.

History · 10 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Corcept Therapeutics P/E ratio, year by year

Corcept Therapeutics (CORT) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today52.7×—$70.07—
202542.4× 3.6% up$34.80$0.82
202441.0× 18.6% up$50.39$1.23
202334.6× 48.0% up$32.48$0.94
202223.3× 4.9% up$20.31$0.87
202122.2× 27.7% down$19.80$0.89
202030.8× 95.9% up$26.16$0.85
201915.7× 29.4% down$12.10$0.77
201822.3× 28.2% up$13.36$0.60
201717.4× 83.3% down$18.06$1.04
2016103.7×—$7.26$0.07
2015——$4.98-$0.06
2014——$3.00—
2013——$3.21—
2012——$1.43—
2011——$3.42—
2010——$3.86—
2009——$2.78—
2008——$1.02—
2007——$3.09—
2006——$1.23—
2005——$3.65—
2004——$6.25—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of Corcept Therapeutics and comparable companies
CompanyP/E ratio
HealthEquity HQY37.7×
Corcept Therapeutics CORT52.7×
PACS Group PACS27.6×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on CORT

Corcept Therapeutics, figure by figure

Corcept Therapeutics (CORT) overview: price, valuation and scorecardAll health care companies by market value

Corcept Therapeutics P/E ratio: questions and answers

What is Corcept Therapeutics's P/E ratio?

Corcept Therapeutics (CORT) trades at 52.7× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 42.4×. That is 3.6% higher than the 41.0× of fiscal 2024.

Is Corcept Therapeutics's P/E ratio high or low compared with its own history?

Today's P/E ratio is higher than at 90% of the 10 fiscal year-ends on record; their median is 27.1×.

What are the highest and lowest P/E ratio figures on record for Corcept Therapeutics?

Across the 10 fiscal year-ends on record (2016–2025), the highest was 103.7× in fiscal 2016 and the lowest 15.7× in fiscal 2019.

How is Corcept Therapeutics's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corcept Therapeutics (CORT) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/CORT/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.